logo munafa.org

NEWS Gainers Losers
 Learn then Earn

 story : BioNTech COVID-19 vaccine antibodies ten times higher than Sinovac's: study #FinanceUSA #StockMarketNEWS Healthcare workers in Hong Kong who received the COVID-19 vaccine from BioNTech showed ten

@stockMarketNEWS 20 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

BioNTech COVID-19 vaccine antibodies ten times higher than Sinovac's: study #FinanceUSA #StockMarketNEWS
Healthcare workers in Hong Kong who received the COVID-19 vaccine from BioNTech showed ten times more antibodies than those who received China's vaccine Sinovac, according to a study published in The Lancet Microbe on Thursday. "The difference in concentrations of neutralising antibodies identified in our study could translate into substantial differences in vaccine effectiveness," according to the research. Blood samples of the participants were collected before vaccination, before the second dose and 21 to 35 days after the second dose and tested for antibodies. A group of 1,442 healthcare workers were enrolled and the study involved complete data on antibody concentrations from 93 of those. The worker who received the BioNTech mRNA vaccine, which involves injecting the virus's genetic code into the body to make proteins to fight it, saw antibodies rise substantially after the first and second doses. The group that received the Sinovac vaccine, which uses dead viral particles to help the body fight, showed low antibody concentrations after the first dose that rose to moderate after the second.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme